Insiders · Profile

NEIL GARRY ARTHUR

CEO and Chairman of the Board at Avalo Therapeutics. Filing since 10 Jun 2020. CIK 0001586785

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jun 2023
CEO and Chairman of the Board
Bought
4,000
$13.68K
43.4%
9 Dec 2022
CEO and Chairman of the Board
Bought
2,083
$9.21K
29.2%
10 Dec 2021
Chief Scientific Officer
Bought
4,267
$6.70K
5.2%
10 Jun 2021
Chief Scientific Officer
Bought
3,692
$8.42K
4.8%
10 Dec 2020
Chief Scientific Officer
Bought
3,599
$8.20K
4.9%
10 Jun 2020
Chief Scientific Officer
Bought
1,799
$4.10K
2.5%
6 decisions on file.